Li Yuyu, Yu Jiaqi, Wang Yuan
Beijing Anzhen Hospital Affiliated to Capital Medical University, 100029 Beijing, China.
Beijing Institute of Heart, Lung and Blood Vessel Disease, 100029 Beijing, China.
Rev Cardiovasc Med. 2024 Oct 12;25(10):367. doi: 10.31083/j.rcm2510367. eCollection 2024 Oct.
ST-segment elevation myocardial infarction patients are best treated with emergency percutaneous coronary intervention (PCI), while coronary microvascular dysfunction and obstruction (CMVO) are indicated by the absence or slowing of antegrade epicardial flow on angiography, resulting in suboptimal myocardial perfusion despite the lack of mechanical vascular obstruction. CMVO occurs in up to half of patients who undergo PCI for the first time and is associated with poor outcomes. This review summarizes the complex mechanisms leading to CMVO and elaborates on the changes observed at the organism, tissue, organ, cellular, and molecular levels. It also describes the current diagnostic methods and comprehensive treatment methods for CMVO.
ST段抬高型心肌梗死患者最好接受紧急经皮冠状动脉介入治疗(PCI),而冠状动脉微血管功能障碍和阻塞(CMVO)在血管造影中表现为心外膜正向血流缺失或减慢,尽管没有机械性血管阻塞,但会导致心肌灌注不佳。CMVO在首次接受PCI的患者中发生率高达一半,且与不良预后相关。本综述总结了导致CMVO的复杂机制,并阐述了在机体、组织、器官、细胞和分子水平观察到的变化。它还描述了CMVO目前的诊断方法和综合治疗方法。